337 related articles for article (PubMed ID: 23750574)
21. [Influence of compliance on the incidence of cardiovascular events and health costs when using single-pill fixed-dose combinations for the treatment of hypertension].
Sicras Mainar A; Galera Llorca J; Muñoz Ortí G; Navarro Artieda R
Med Clin (Barc); 2011 Feb; 136(5):183-91. PubMed ID: 21106209
[TBL] [Abstract][Full Text] [Related]
22. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
[TBL] [Abstract][Full Text] [Related]
23. Targeted clinical audits immediately following the establishment of clinical practice guidelines for multiple sclerosis in 17 neurology departments: A pragmatic and collaborative study.
Lairy G; Zephir H; Ouallet JC; Le Page E; Laplaud D; Bensa C; De Seze J
Rev Neurol (Paris); 2015 May; 171(5):407-14. PubMed ID: 25912471
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit.
Peiris D; Murray J; Scully D; Tilakawardene V; Hetaraka-Stevens L; Stewart T; Patel A
N Z Med J; 2008 Nov; 121(1285):35-46. PubMed ID: 19079435
[TBL] [Abstract][Full Text] [Related]
25. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
26. Beyond hypertension toward guidelines for cardiovascular risk reduction.
Volpe M; Alderman MH; Furberg CD; Jackson R; Kostis JB; Laragh JH; Psaty BM; Ruilope LM
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1068-74. PubMed ID: 15533736
[TBL] [Abstract][Full Text] [Related]
27. Patient handover in the oncology setting: an evidence utilisation project.
Kasinathan S; Ang E; Lee J
Int J Evid Based Healthc; 2012 Dec; 10(4):369-76. PubMed ID: 23173661
[TBL] [Abstract][Full Text] [Related]
28. Total cardiovascular risk: a new treatment concept.
Mancia G
J Hypertens Suppl; 2006 Apr; 24(2):S17-24. PubMed ID: 16601556
[TBL] [Abstract][Full Text] [Related]
29. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
30. Secondary prevention of stroke in Saskatchewan, Canada: hypertension control.
Bartsch JA; Teare GF; Neufeld A; Hudema N; Muhajarine N
Int J Stroke; 2013 Oct; 8 Suppl A100():32-8. PubMed ID: 23088414
[TBL] [Abstract][Full Text] [Related]
31. Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial.
Lüders S; Schrader J; Schmieder RE; Smolka W; Wegscheider K; Bestehorn K
Eur J Cardiovasc Prev Rehabil; 2010 Jun; 17(3):271-9. PubMed ID: 19901841
[TBL] [Abstract][Full Text] [Related]
32. Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence-based guidelines.
Varis J; Savola H; Vesalainen R; Kantola I
Blood Press; 2009; 18(1-2):62-7. PubMed ID: 19353413
[TBL] [Abstract][Full Text] [Related]
33. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
[TBL] [Abstract][Full Text] [Related]
34. Hypertension strategies for therapeutic intervention and prevention of end-organ damage.
Houston MC
Prim Care; 1991 Sep; 18(3):713-53. PubMed ID: 1946795
[TBL] [Abstract][Full Text] [Related]
35. Maintenance of patency of central venous access devices by registered nurses in an acute ambulatory setting: an evidence utilisation project.
Chong LM; Chow YL; Kong SS; Ang E
Int J Evid Based Healthc; 2013 Mar; 11(1):20-5. PubMed ID: 23448326
[TBL] [Abstract][Full Text] [Related]
36. The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure.
Zarnke KB; Levine M; McAlister FA; Campbell NR; Myers MG; McKay DW; Bolli P; Honos G; Lebel M; Mann K; Wilson TW; Abbott C; Tobe S; Burgess E; Rabkin S;
Can J Cardiol; 2001 Dec; 17(12):1249-63. PubMed ID: 11773936
[TBL] [Abstract][Full Text] [Related]
37. How early should blood pressure control be achieved for optimal cardiovascular outcomes?
Weir MR; Zappe D; Orloski LA; Sowers JR
J Hum Hypertens; 2011 Apr; 25(4):211-7. PubMed ID: 20596060
[TBL] [Abstract][Full Text] [Related]
38. Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study.
Grassi G; Cifkova R; Laurent S; Narkiewicz K; Redon J; Farsang C; Viigimaa M; Erdine S; Brambilla G; Bombelli M; Dell'Oro R; Notari M; Mancia G
Eur Heart J; 2011 Jan; 32(2):218-25. PubMed ID: 21047877
[TBL] [Abstract][Full Text] [Related]
39. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
Mancia G; Parati G; Bilo G; Choi J; Kilama MO; Ruilope LM;
J Hypertens; 2011 Mar; 29(3):600-9. PubMed ID: 21252701
[TBL] [Abstract][Full Text] [Related]
40. Clinical decision support to improve blood pressure control in hemodialysis patients: a nonrandomized controlled trial.
Thompson S; Hemmelgarn B; Wiebe N; Majumdar S; Klarenbach S; Jindal K; Manns B; Mortis G; Campbell P; Tonelli M;
J Nephrol; 2012; 25(6):944-53. PubMed ID: 23147684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
